SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

GSK mRNA flu vaccine advances to Phase III testing

GSK’s mRNA flu vaccine has moved into Phase III testing.

GSK

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.